Our study demonstrates a key mechanism of DIRAS1 in chemotherapy resistance of CRC and proposes a novel molecular pathway that promotes tumor cell resistance by regulating PHB1 to maintain mitochondrial homeostasis, which provides new theoretical basis and potential clinical strategies for targeted drug resistance. Here, DIRAS1 is linked to neoplasm.